Cited by 116Lymphatic System and DiseasesLymphatic Disorders and TreatmentsParasitic Diseases Research and Treatment

Th2 cytokines inhibit lymphangiogenesis

Open access
Savetsky, Ira L., Ghanta, Swapna, Gardenier, Jason C., Torrisi, Jeremy S., García Nores, Gabriela D., Hespe, Geoffrey E., Nitti, Matthew D., Kataru, Raghu P. +1 more·2015·PLOS ONE

Abstract

Lymphangiogenesis is the process by which new lymphatic vessels grow in response to pathologic stimuli such as wound healing, inflammation, and tumor metastasis. It is well-recognized that growth factors and cytokines regulate lymphangiogenesis by promoting or inhibiting lymphatic endothelial cell (LEC) proliferation, migration and differentiation. Our group has shown that the expression of T-helper 2 (Th2) cytokines is markedly increased in lymphedema, and that these cytokines inhibit lymphatic function by increasing fibrosis and promoting changes in the extracellular matrix. However, while the evidence supporting a role for T cells and Th2 cytokines as negative regulators of lymphatic function is clear, the direct effects of Th2 cytokines on isolated LECs remains poorly understood. Using in vitro and in vivo studies, we show that physiologic doses of interleukin-4 (IL-4) and interleukin-13 (IL-13) have profound anti-lymphangiogenic effects and potently impair LEC survival, proliferation, migration, and tubule formation. Inhibition of these cytokines with targeted monoclonal antibodies in the cornea suture model specifically increases inflammatory lymphangiogenesis without concomitant changes in angiogenesis. These findings suggest that manipulation of anti-lymphangiogenic pathways may represent a novel and potent means of improving lymphangiogenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0126908

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Th2 cytokines IL-4 and IL-13 are linked to reduced LEC viability and LEC gene expression.

    “the Th2 cytokines IL-4 and IL-13 are linked to reduced LEC viability and LEC gene expression (143).”

    From Transport and Immune Functions of the Lymphatic System. (2025) · cites this paper as [143]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Savetsky, I. L., Ghanta, S., Gardenier, J. C., Torrisi, J. S., García Nores, G. D., Hespe, G. E., Nitti, M. D., Kataru, R. P., & Mehrara, B. J.
Affiliations
Memorial Sloan Kettering Cancer Center (US)
Corresponding author
Mehrara, Babak J.
Venue
PLOS ONE
Published
2015-06-03
Volume
10
Issue
6
Pages
e0126908
ISSN
1932-6203 (ISSN-L)
OpenAlex
W560736474
Cited by
114
References
23
Citations by year
2026: 8 · 2025: 11 · 2024: 11 · 2023: 6 · 2022: 18 · 2021: 10 · 2020: 11 · 2019: 8 · 2018: 11 · 2017: 12 · 2016: 6 · 2015: 2
FWCI
4.51
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Memorial Sloan-Kettering Cancer Center (CA008748, P30 CA008748)
  • National Heart, Lung, and Blood Institute (R01HL111130)
  • National Cancer Institute (T32CA009685, P30CA008748, T32CA009501)
Topics
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
  • Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
Keywords
lymphangiogenesis, Th2 cytokines, IL-4, IL-13, lymphatic endothelial cells, lymphedema, anti-lymphangiogenic therapy, lymphatic fibrosis, extracellular matrix, monoclonal antibodies
MeSH terms
Animals, Cell Movement, Cell Survival, Male, Interleukin-4, Th2 Cells, Interleukin-13, Lymphangiogenesis, Endothelial Cells, Cell Proliferation, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review